Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromaffin Cells | 10 | 2010 | 37 | 1.600 |
Why?
|
| Caffeine | 3 | 2023 | 86 | 0.960 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 18 | 0.780 |
Why?
|
| Exocytosis | 5 | 2012 | 110 | 0.760 |
Why?
|
| Catecholamines | 7 | 2014 | 92 | 0.710 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2012 | 15 | 0.630 |
Why?
|
| Isoflurane | 4 | 2017 | 69 | 0.520 |
Why?
|
| Hypoxia | 8 | 2015 | 683 | 0.500 |
Why?
|
| Synaptic Vesicles | 3 | 2012 | 40 | 0.480 |
Why?
|
| Rats | 16 | 2023 | 4134 | 0.470 |
Why?
|
| Secretory Vesicles | 2 | 2006 | 43 | 0.470 |
Why?
|
| Calcium Channels, P-Type | 2 | 2007 | 10 | 0.470 |
Why?
|
| Calcium Channels, N-Type | 2 | 2007 | 18 | 0.460 |
Why?
|
| Calcium | 10 | 2015 | 1205 | 0.450 |
Why?
|
| Anesthetics, General | 2 | 2017 | 11 | 0.420 |
Why?
|
| Adrenal Medulla | 5 | 2009 | 49 | 0.410 |
Why?
|
| Synaptotagmin I | 1 | 2012 | 16 | 0.390 |
Why?
|
| Neurons | 6 | 2013 | 1654 | 0.380 |
Why?
|
| Synaptic Transmission | 2 | 2010 | 233 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2023 | 1264 | 0.320 |
Why?
|
| Calcium Channels, T-Type | 3 | 2015 | 25 | 0.310 |
Why?
|
| Patch-Clamp Techniques | 7 | 2010 | 403 | 0.300 |
Why?
|
| Animals | 25 | 2023 | 28924 | 0.300 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 102 | 0.290 |
Why?
|
| Calcium Channels | 2 | 2014 | 183 | 0.290 |
Why?
|
| Neurotransmitter Agents | 2 | 2006 | 111 | 0.280 |
Why?
|
| PC12 Cells | 5 | 2013 | 111 | 0.280 |
Why?
|
| Propofol | 3 | 2013 | 95 | 0.280 |
Why?
|
| Carotid Body | 3 | 2015 | 242 | 0.260 |
Why?
|
| Cells, Cultured | 9 | 2014 | 2943 | 0.260 |
Why?
|
| Transfection | 2 | 2006 | 907 | 0.250 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 2006 | 2 | 0.250 |
Why?
|
| Calcium Signaling | 2 | 2007 | 142 | 0.240 |
Why?
|
| Gene Silencing | 1 | 2006 | 181 | 0.230 |
Why?
|
| Anesthesia, General | 2 | 2017 | 127 | 0.220 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 1028 | 0.210 |
Why?
|
| Receptors, Adrenergic | 1 | 2023 | 15 | 0.200 |
Why?
|
| Potassium Channels | 2 | 2002 | 359 | 0.200 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2023 | 7 | 0.200 |
Why?
|
| Pheochromocytoma | 1 | 2003 | 51 | 0.200 |
Why?
|
| Hydrogen Sulfide | 2 | 2014 | 54 | 0.200 |
Why?
|
| Drug Repositioning | 1 | 2023 | 26 | 0.200 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 235 | 0.190 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 84 | 0.190 |
Why?
|
| Electric Stimulation | 4 | 2006 | 397 | 0.190 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2002 | 18 | 0.190 |
Why?
|
| Anesthetics, Intravenous | 2 | 2013 | 43 | 0.190 |
Why?
|
| Cerebellar Diseases | 1 | 2002 | 23 | 0.190 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2002 | 8 | 0.190 |
Why?
|
| Antioxidants | 2 | 2010 | 233 | 0.180 |
Why?
|
| Etomidate | 2 | 2012 | 11 | 0.180 |
Why?
|
| Phenols | 1 | 2002 | 42 | 0.180 |
Why?
|
| Catechin | 1 | 2002 | 22 | 0.180 |
Why?
|
| Neuropeptides | 1 | 2002 | 116 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2002 | 58 | 0.180 |
Why?
|
| Flavonoids | 1 | 2002 | 85 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 120 | 0.180 |
Why?
|
| Cattle | 4 | 2002 | 387 | 0.180 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2002 | 124 | 0.180 |
Why?
|
| Cerebellum | 1 | 2002 | 253 | 0.170 |
Why?
|
| Polymers | 1 | 2002 | 219 | 0.170 |
Why?
|
| Plant Extracts | 1 | 2002 | 248 | 0.160 |
Why?
|
| SNARE Proteins | 2 | 2009 | 26 | 0.150 |
Why?
|
| Animals, Newborn | 6 | 2012 | 535 | 0.140 |
Why?
|
| Membrane Potentials | 4 | 2010 | 442 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 1351 | 0.140 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2017 | 6 | 0.130 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2017 | 14 | 0.130 |
Why?
|
| Cystathionine gamma-Lyase | 2 | 2014 | 35 | 0.120 |
Why?
|
| Gene Expression | 2 | 2012 | 1321 | 0.120 |
Why?
|
| Mice | 8 | 2015 | 12559 | 0.110 |
Why?
|
| Anesthesia Recovery Period | 1 | 2013 | 55 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2007 | 696 | 0.090 |
Why?
|
| Oxygen | 3 | 2014 | 787 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 567 | 0.080 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 26 | 0.080 |
Why?
|
| Mutation | 3 | 2009 | 4371 | 0.080 |
Why?
|
| NADPH Oxidases | 1 | 2010 | 85 | 0.080 |
Why?
|
| Syntaxin 1 | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cyclobutanes | 1 | 2009 | 8 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 134 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 467 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 3489 | 0.080 |
Why?
|
| Hippocampus | 2 | 2010 | 459 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1969 | 0.070 |
Why?
|
| Heart | 1 | 2012 | 591 | 0.070 |
Why?
|
| Action Potentials | 2 | 2002 | 618 | 0.070 |
Why?
|
| Nicotine | 2 | 2010 | 210 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 554 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 148 | 0.070 |
Why?
|
| trans-Golgi Network | 1 | 2006 | 15 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 232 | 0.060 |
Why?
|
| Colforsin | 2 | 2017 | 75 | 0.060 |
Why?
|
| Chromaffin Granules | 1 | 2005 | 1 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2006 | 213 | 0.060 |
Why?
|
| Digitonin | 1 | 2005 | 10 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2005 | 71 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 291 | 0.060 |
Why?
|
| Cell Size | 1 | 2005 | 71 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 138 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 117 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 303 | 0.060 |
Why?
|
| Lung | 1 | 2012 | 1382 | 0.060 |
Why?
|
| Nicotinic Agonists | 1 | 2005 | 74 | 0.050 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 1010 | 0.050 |
Why?
|
| Sulfides | 2 | 2014 | 69 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 62 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 53 | 0.050 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2002 | 9 | 0.050 |
Why?
|
| Calpain | 1 | 2003 | 113 | 0.050 |
Why?
|
| Semliki forest virus | 1 | 2002 | 8 | 0.050 |
Why?
|
| Neuronal Calcium-Sensor Proteins | 1 | 2002 | 3 | 0.050 |
Why?
|
| Electric Capacitance | 1 | 2002 | 7 | 0.050 |
Why?
|
| Adrenal Glands | 1 | 2002 | 78 | 0.050 |
Why?
|
| Histamine | 1 | 2002 | 124 | 0.050 |
Why?
|
| Cell Hypoxia | 2 | 2015 | 188 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 81 | 0.050 |
Why?
|
| Cadmium Chloride | 2 | 2012 | 12 | 0.050 |
Why?
|
| Cell Death | 1 | 2002 | 265 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2002 | 407 | 0.040 |
Why?
|
| Endocytosis | 1 | 2002 | 186 | 0.040 |
Why?
|
| Calcium Channel Blockers | 2 | 2012 | 122 | 0.040 |
Why?
|
| Potassium Chloride | 2 | 2012 | 88 | 0.040 |
Why?
|
| Sodium | 1 | 2002 | 340 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2002 | 446 | 0.040 |
Why?
|
| Electrochemistry | 2 | 2010 | 60 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 517 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 559 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 205 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2002 | 338 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 1562 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 623 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2002 | 434 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2012 | 656 | 0.040 |
Why?
|
| Protein Binding | 1 | 2002 | 1562 | 0.040 |
Why?
|
| Time Factors | 2 | 2009 | 5577 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2785 | 0.030 |
Why?
|
| Triazoles | 1 | 2017 | 110 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2017 | 284 | 0.030 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 13 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 386 | 0.030 |
Why?
|
| Chemoreceptor Cells | 1 | 2014 | 65 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 439 | 0.030 |
Why?
|
| Theophylline | 1 | 2013 | 34 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 319 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 706 | 0.030 |
Why?
|
| Nifedipine | 1 | 2012 | 26 | 0.020 |
Why?
|
| Alkynes | 1 | 2012 | 21 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 96 | 0.020 |
Why?
|
| CpG Islands | 1 | 2012 | 169 | 0.020 |
Why?
|
| Male | 4 | 2015 | 45735 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2163 | 0.020 |
Why?
|
| Metalloporphyrins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Cadmium | 1 | 2009 | 30 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 798 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2009 | 26 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 311 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 741 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2012 | 703 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2480 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2092 | 0.010 |
Why?
|
| Humans | 2 | 2015 | 95971 | 0.010 |
Why?
|
| NADP | 1 | 2003 | 49 | 0.010 |
Why?
|
| Dipeptides | 1 | 2003 | 40 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 205 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2003 | 411 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2059 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2003 | 313 | 0.010 |
Why?
|
| Glucose | 1 | 2003 | 701 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 1190 | 0.010 |
Why?
|
| Female | 2 | 2010 | 49938 | 0.010 |
Why?
|